BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome


You May Also Like

Celsion Corporation Announces Issuance of Two New Patents for ThermoDox®

LAWRENCEVILLE, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical stage ...

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

Biosimilar Hyrimoz® (adalimumab) approved for use in all same indications as reference medicine*** including ...